$SENS
Senseonics Holdings, Inc. Stock $sens

$sens Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000155837021007068 Filed on May 13, 2021

Income Statement

Concept	2021 Q2	2021 Q1	2020 Q1
Revenue	$3.289M	$2.846M	$36.00K
YoY Change	1160.15%	7805.56%	-98.95%
Cost Of Revenue	$2.897M	$2.320M	$19.67M
YoY Change	106.34%	-88.21%	192.14%
Gross Profit	$392.0K	$526.0K	-$19.63M
YoY Change	-134.3%	-102.68%	493.17%
Gross Profit Margin	11.92%	18.48%	-54538.89%
Selling, General & Admin	$9.175M	$6.587M	$16.84M
YoY Change	20.93%	-60.87%	-13.0%
% of Gross Profit	2340.56%	1252.28%
Research & Development	$7.107M	$5.255M	$7.362M
YoY Change	87.22%	-28.62%	3.57%
% of Gross Profit	1813.01%	999.05%
Depreciation & Amortization	$296.0K	$316.0K	$288.0K
YoY Change	5.34%	9.72%	44.0%
% of Gross Profit	75.51%	60.08%
Operating Expenses	$16.28M	$11.84M	$24.20M
YoY Change	43.04%	-51.06%	-8.55%
Operating Profit	-$15.89M	-$11.32M	-$43.83M
YoY Change	26.86%	-74.18%	47.24%
Interest Expense	$4.034M	$4.058M	$4.373M
YoY Change	13.47%	-7.2%	557.59%
% of Operating Profit
Other Income/Expense, Net	-$164.4M	-$238.2M	$1.238M
YoY Change	-3381.1%	-19340.55%	-572.52%
Pretax Income	-$180.3M	-$249.5M	-$42.59M
YoY Change	2299.28%	485.81%	45.05%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$180.3M	-$249.5M	-$42.59M
YoY Change	2299.28%	485.81%	45.05%
Net Earnings / Revenue	-5482.09%	-8767.18%	-118313.89%
Basic Earnings Per Share		-$0.68
Diluted Earnings Per Share	-$417.5K	-$0.68	-$209.0K
COMMON SHARES
Basic Shares Outstanding	428.1M	364.3M
Diluted Shares Outstanding		364.3M

Balance Sheet

Concept	2021 Q2	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$215.0M	$178.6M	$18.61M
YoY Change	904.86%	860.01%	-82.05%
Cash & Equivalents	$69.75M	$178.6M	$18.81M
Short-Term Investments	$145.3M
Other Short-Term Assets	$4.533M	$4.451M	$5.940M
YoY Change	-23.01%	-25.07%	26.44%
Inventory	$8.816M	$6.584M	$4.995M
Prepaid Expenses
Receivables	$2.791M	$1.686M	$996.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$179.2M	$191.3M	$30.54M
YoY Change	458.27%	526.58%	-75.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.391M	$1.463M	$1.803M
YoY Change	-21.46%	-18.86%	-56.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$51.92M
YoY Change	1123.06%
Other Assets	$2.584M	$3.153M	$2.930M
YoY Change	-4.86%	7.61%	2470.18%
Total Long-Term Assets	$55.89M	$4.616M	$4.733M
YoY Change	540.11%	-2.47%	10.3%
TOTAL ASSETS
Total Short-Term Assets	$179.2M	$191.3M	$30.54M
Total Long-Term Assets	$55.89M	$4.616M	$4.733M
Total Assets	$235.1M	$195.9M	$35.27M
YoY Change	475.76%	455.58%	-72.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.032M	$930.0K	$2.490M
YoY Change	2760.38%	-62.65%	-23.95%
Accrued Expenses	$11.11M	$9.449M	$15.32M
YoY Change	-8.41%	-38.33%	10.87%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.763M	$5.123M	$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$20.02M	$15.69M	$17.86M
YoY Change	63.03%	-12.17%	-34.95%
LONG-TERM LIABILITIES
Long-Term Debt	$54.66M	$52.95M	$64.28M
YoY Change	-10.67%	-17.63%	63.58%
Other Long-Term Liabilities	$1.049M	$1.269M	$2.089M
YoY Change	-44.64%	-39.25%	-88.83%
Total Long-Term Liabilities	$1.049M	$1.269M	$66.37M
YoY Change	-44.64%	-98.09%	14.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.02M	$15.69M	$17.86M
Total Long-Term Liabilities	$1.049M	$1.269M	$66.37M
Total Liabilities	$547.8M	$381.8M	$84.23M
YoY Change	580.94%	353.34%	-1.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.100B	-$898.0M
YoY Change	110.14%
Common Stock	$445.0K	$428.0K
YoY Change	92.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$312.6M	-$185.9M	-$48.96M
YoY Change
Total Liabilities & Shareholders Equity	$235.1M	$195.9M	$35.27M
YoY Change	475.76%	455.58%	-72.74%

Cashflow Statement

Concept	2021 Q2	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$180.3M	-$249.5M	-$42.59M
YoY Change	2299.28%	485.81%	45.05%
Depreciation, Depletion And Amortization	$296.0K	$316.0K	$288.0K
YoY Change	5.34%	9.72%	44.0%
Cash From Operating Activities	-$14.15M	-$16.26M	-$29.05M
YoY Change	-15.42%	-44.03%	-3.66%
INVESTING ACTIVITIES
Capital Expenditures	-$36.00K	-$11.00K	-$100.0K
YoY Change	-53.85%	-89.0%	-74.49%
Acquisitions
YoY Change
Other Investing Activities	-$145.3M		$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$145.3M	-$11.00K	-$100.0K
YoY Change	186191.03%	-89.0%	-79.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$100.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	50.60M	176.7M	-47.99M
YoY Change	158.18%	-468.19%	1838.0%
NET CHANGE
Cash From Operating Activities	-14.15M	-16.26M	-29.05M
Cash From Investing Activities	-145.3M	-11.00K	-100.0K
Cash From Financing Activities	50.60M	176.7M	-47.99M
Net Change In Cash	-108.9M	160.4M	-77.13M
YoY Change	-3998.85%	-307.96%	132.9%
FREE CASH FLOW
Cash From Operating Activities	-$14.15M	-$16.26M	-$29.05M
Capital Expenditures	-$36.00K	-$11.00K	-$100.0K
Free Cash Flow	-$14.11M	-$16.25M	-$28.95M
YoY Change	-15.24%	-43.88%	-2.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	427914984
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	265582688
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	SENSEONICS HOLDINGS, INC.
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001616543
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	3000
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-37717
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-1210911
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	20451 Seneca Meadows Parkway
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876-7005
CY2021Q1	dei	City Area Code CityAreaCode	301
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	515-7260
CY2021Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2021Q1	dei	Trading Symbol TradingSymbol	SENS
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	428072196
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	178610000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18005000
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	200000
CY2021Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	334000
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	565000
CY2021Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	1352000
CY2020Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	2421000
CY2021Q1	us-gaap	Inventory Net InventoryNet	6584000
CY2020Q4	us-gaap	Inventory Net InventoryNet	5281000
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4451000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3774000
CY2021Q1	us-gaap	Assets Current AssetsCurrent	191331000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	30246000
CY2021Q1	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	1104000
CY2020Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	1886000
CY2021Q1	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	2049000
CY2020Q4	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	2229000
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1463000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1557000
CY2021Q1	us-gaap	Assets Assets	195947000
CY2020Q4	us-gaap	Assets Assets	35918000
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	930000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1762000
CY2021Q1	sens	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	9635000
CY2020Q4	sens	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	11674000
CY2021Q1	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	5123000
CY2020Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	3202000
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	15688000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16638000
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	52948000
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	57216000
CY2021Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	243018000
CY2020Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	62119000
CY2021Q1	sens	Long Term Options LongTermOptions	68923000
CY2020Q4	sens	Long Term Options LongTermOptions	39734000
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1269000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1483000
CY2021Q1	us-gaap	Liabilities Liabilities	381846000
CY2020Q4	us-gaap	Liabilities Liabilities	177190000
CY2021Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	3000
CY2020Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	2811000
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2811000
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	427914984
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	265582688
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	428000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	266000
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	711698000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	504162000
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-898025000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-648511000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-185899000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-144083000
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	195947000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35918000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	487000
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31000
CY2021Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	2359000
CY2020Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	5000
CY2021Q1	us-gaap	Revenues Revenues	2846000
CY2020Q1	us-gaap	Revenues Revenues	36000
CY2021Q1	sens	Cost Of Goods And Services Sold Net CostOfGoodsAndServicesSoldNet	2320000
CY2020Q1	sens	Cost Of Goods And Services Sold Net CostOfGoodsAndServicesSoldNet	19670000
CY2021Q1	us-gaap	Gross Profit GrossProfit	526000
CY2020Q1	us-gaap	Gross Profit GrossProfit	-19634000
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1613000
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11145000
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5255000
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7362000
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4974000
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5690000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-11316000
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-43831000
CY2021Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	9000
CY2020Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	209000
CY2021Q1	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	-52675000
CY2021Q1	sens	Gains Losses On Extinguishment Of Debt And Gain Loss On Stock Conversion GainsLossesOnExtinguishmentOfDebtAndGainLossOnStockConversion	330000
CY2020Q1	sens	Gains Losses On Extinguishment Of Debt And Gain Loss On Stock Conversion GainsLossesOnExtinguishmentOfDebtAndGainLossOnStockConversion	-4546000
CY2021Q1	us-gaap	Interest Expense InterestExpense	4058000
CY2020Q1	us-gaap	Interest Expense InterestExpense	4373000
CY2021Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-180899000
CY2020Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	10311000
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	782000
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-123000
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-363000
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-238198000
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1238000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-249514000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-42593000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-249514000
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-42593000
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.68
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6501000
CY2021Q1	sens	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options And Restricted Stock Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAndRestrictedStockRequisiteServicePeriodRecognition	1844000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-249514000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-185899000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-249514000
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-42593000
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	364274433
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	203745974
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-8649000
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-86000
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	498000
CY2020Q1	sens	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options And Restricted Stock Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAndRestrictedStockRequisiteServicePeriodRecognition	1869000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-42593000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-48961000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-144083000
CY2021Q1	sens	Shares Issued During Period Value Conversion Of Temporary Equity SharesIssuedDuringPeriodValueConversionOfTemporaryEquity	45567000
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	152087000
CY2021Q1	sens	Exercise Of Stock Options Vesting Of Rs Us And Espp Purchases ExerciseOfStockOptionsVestingOfRSUsAndESPPPurchases	1699000
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	316000
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	288000
CY2021Q1	sens	Amortization Of Financing Costs Discounts And Deferred Costs AmortizationOfFinancingCostsDiscountsAndDeferredCosts	972000
CY2020Q1	sens	Amortization Of Financing Costs Discounts And Deferred Costs AmortizationOfFinancingCostsDiscountsAndDeferredCosts	2191000
CY2021Q1	sens	Fair Value Adjustment Derivative Liability FairValueAdjustmentDerivativeLiability	180899000
CY2020Q1	sens	Fair Value Adjustment Derivative Liability FairValueAdjustmentDerivativeLiability	-10311000
CY2021Q1	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	-52675000
CY2021Q1	sens	Gains Losses On Extinguishment Of Debt And Gain Loss On Stock Conversion GainsLossesOnExtinguishmentOfDebtAndGainLossOnStockConversion	330000
CY2020Q1	sens	Gains Losses On Extinguishment Of Debt And Gain Loss On Stock Conversion GainsLossesOnExtinguishmentOfDebtAndGainLossOnStockConversion	-4546000
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	782000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1740000
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1869000
CY2020Q1	us-gaap	Inventory Write Down InventoryWriteDown	12551000
CY2020Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-181000
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1301000
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-9384000
CY2021Q1	sens	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	677000
CY2020Q1	sens	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	1229000
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1303000
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	617000
CY2021Q1	sens	Increase Decrease In Deposit Assets And Other Assets IncreaseDecreaseInDepositAssetsAndOtherAssets	30000
CY2020Q1	sens	Increase Decrease In Deposit Assets And Other Assets IncreaseDecreaseInDepositAssetsAndOtherAssets	57000
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-833000
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1795000
CY2021Q1	sens	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-3411000
CY2020Q1	sens	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-2305000
CY2021Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1155000
CY2020Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-1151000
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16258000
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29048000
CY2021Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	11000
CY2020Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	100000
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11000
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-100000
CY2021Q1	sens	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	152087000
CY2020Q1	sens	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	-87000
CY2021Q1	sens	Proceeds From Exercise Of Stock Options And Stock Warrants ProceedsFromExerciseOfStockOptionsAndStockWarrants	1804000
CY2020Q1	sens	Proceeds From Exercise Of Stock Options And Stock Warrants ProceedsFromExerciseOfStockOptionsAndStockWarrants	498000
CY2020Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	48396000
CY2021Q1	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	22783000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	176674000
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-47985000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	160405000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-77133000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18205000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95938000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	178610000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18805000
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1927000
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	3344000
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	48000
CY2021Q1	sens	Common Stock Issued Converted From Preferred Shares CommonStockIssuedConvertedFromPreferredShares	54166000
CY2021Q1	sens	Common Stock Issued1 CommonStockIssued1	4925000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-175200000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-115500000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-94000000.0
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-898000000.0
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	178600000
CY2020Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	3000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	178610000
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses during the reporting period. In the accompanying unaudited consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, recoverability of long-lived assets, deferred taxes and valuation allowances, derivative assets and liabilities, obsolete inventory, warranty obligations, variable consideration related to revenue, depreciable lives of property and equipment, and accruals for clinical study costs, which are accrued based on estimates of work performed under contract. The Company considered COVID-19 related impacts to its estimates, as appropriate, within its unaudited condensed consolidated financial statements and there may be changes to those estimates in future periods due to the uncertainties surrounding the severity and duration of the COVID-19 pandemic. Actual results could differ from those estimates; however, management does not believe that such differences would be material.</p>
CY2021Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2021Q1	us-gaap	Cash Cash	8607000
CY2020Q4	us-gaap	Cash Cash	18002000
CY2021Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	170003000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18005000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	178610000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18005000
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	200000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	178610000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18205000
CY2021Q1	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:14pt 0pt 0pt 0pt;"><span style="font-style:italic;font-weight:bold;">Warranty Obligation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-indent:36pt;margin:14pt 0pt 0pt 0pt;"><span style="font-size:10pt;">The Company provides a warranty of </span><span style="font-size:10pt;">one year</span><span style="font-size:10pt;"> on its smart transmitters. Additionally, the Company may also replace Eversense system components that do not function in accordance with the product specifications. Estimated replacement costs are recorded at the time of shipment as a charge to cost of sales in the consolidated statement of operations and are developed by analyzing product performance data and historical replacement experience, including comparing actual replacements to revenue.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:14pt 0pt 0pt 0pt;">At March 31, 2021 and December 31, 2020, the warranty reserve for both periods was $0.6 million. The decrease in warranty reserve balance was attributable to the decrease in warranty provisions during the period as a result of the temporary suspension of commercial sales of Eversense. The following table provides a reconciliation of the change in estimated warranty liabilities for the three months ended March 31, 2021 and for the twelve months ended December 31, 2020 (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:52.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:23.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;margin-bottom:0pt;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-style:italic;margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"> </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:23.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"> </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Balance at beginning of the period</p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:21.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 646</p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 2,197</p></td></tr><tr><td style="vertical-align:bottom;width:52.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Provision for warranties during the period</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (29)</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (266)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Settlements made during the period</p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:21.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (60)</p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (1,285)</p></td></tr><tr><td style="vertical-align:bottom;width:52.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Balance at end of the period</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 557</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 646</p></td></tr></table>
CY2021Q1	sens	Product Warranty Term ProductWarrantyTerm	P1Y
CY2021Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	646000
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2197000
CY2021Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	29000
CY2020	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	266000
CY2021Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	60000
CY2020	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1285000
CY2021Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	557000
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	646000
CY2021Q1	sens	Payment Period PaymentPeriod	P60D
CY2020Q1	sens	Number Of Geographical Markets NumberOfGeographicalMarkets	2
CY2021Q1	sens	Number Of Geographical Markets NumberOfGeographicalMarkets	2
CY2020Q4	sens	Prepaid Information Technology And Software Costs Current PrepaidInformationTechnologyAndSoftwareCostsCurrent	150000
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	154031304
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	93805180
CY2021Q1	sens	Prepaid Information Technology And Software Costs Current PrepaidInformationTechnologyAndSoftwareCostsCurrent	152000
CY2021Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	556000
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	203000
CY2021Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3562000
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2626000
CY2021Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	2466000
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	2452000
CY2021Q1	us-gaap	Inventory Net InventoryNet	6584000
CY2020Q4	us-gaap	Inventory Net InventoryNet	5281000
CY2021Q1	sens	Prepaid Contract Manufacturing Current PrepaidContractManufacturingCurrent	3345000
CY2020Q4	sens	Prepaid Contract Manufacturing Current PrepaidContractManufacturingCurrent	3324000
CY2021Q1	us-gaap	Prepaid Insurance PrepaidInsurance	294000
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	50000
CY2021Q1	us-gaap	Prepaid Advertising PrepaidAdvertising	292000
CY2020Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	53000
CY2021Q1	us-gaap	Prepaid Rent PrepaidRent	102000
CY2020Q4	us-gaap	Prepaid Rent PrepaidRent	102000
CY2021Q1	sens	Unbilled Revenue UnbilledRevenue	86000
CY2021Q1	sens	Consulting Consulting	82000
CY2020Q4	sens	Consulting Consulting	84000
CY2021Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	71000
CY2021Q1	sens	Prepaid Clinical And Preclinical Costs PrepaidClinicalAndPreclinicalCosts	23000
CY2020Q4	sens	Prepaid Clinical And Preclinical Costs PrepaidClinicalAndPreclinicalCosts	11000
CY2021Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	4000
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4451000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3774000
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	186000
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	151000
CY2021Q1	sens	Accrued Patient Access And Incentive Programs Current AccruedPatientAccessAndIncentiveProgramsCurrent	119000
CY2020Q4	sens	Accrued Patient Access And Incentive Programs Current AccruedPatientAccessAndIncentiveProgramsCurrent	208000
CY2021Q1	sens	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	9635000
CY2020Q4	sens	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	11674000
CY2021Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1771000
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2217000
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	67000
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3183000
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	7238000
CY2020Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2180000
CY2020Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1891000
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	58000
CY2020Q1	sens	Final Payment Fee Debt FinalPaymentFeeDebt	240000
CY2020Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	4369000
CY2021Q1	us-gaap	Interest Payable Current InterestPayableCurrent	2929000
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1773000
CY2021Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1472000
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	880000
CY2021Q1	sens	Accrued Contract Manufacturing Costs Current AccruedContractManufacturingCostsCurrent	1192000
CY2020Q4	sens	Accrued Contract Manufacturing Costs Current AccruedContractManufacturingCostsCurrent	1421000
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1095000
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4344000
CY2021Q1	sens	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	835000
CY2020Q4	sens	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	842000
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	821000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	794000
CY2021Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	557000
CY2020Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	646000
CY2021Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	429000
CY2020Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	615000
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2561000
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	15700000
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	35000000
CY2021Q1	sens	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	51199000
CY2021Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	107662000
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3202000
CY2020Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	175289
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	100000
CY2021Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	99740259
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0

Files In Submission

Name	View Source	Status
0001558370-21-007068-index-headers.html	Edgar Link	pending
0001558370-21-007068-index.html	Edgar Link	pending
0001558370-21-007068.txt	Edgar Link	pending
0001558370-21-007068-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sens-20210331.xsd	Edgar Link	pending
sens-20210331x10q.htm	Edgar Link	pending
sens-20210331x10q_htm.xml	Edgar Link	completed
sens-20210331xex31d1.htm	Edgar Link	pending
sens-20210331xex31d2.htm	Edgar Link	pending
sens-20210331xex32d1.htm	Edgar Link	pending
sens-20210331_cal.xml	Edgar Link	unprocessable
sens-20210331_def.xml	Edgar Link	unprocessable
sens-20210331_lab.xml	Edgar Link	unprocessable
sens-20210331_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SENS
Senseonics Holdings, Inc. Stock $sens

2021 Q2 Form 10-Q Financial Statement

#000155837021007068 Filed on May 13, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SENS Senseonics Holdings, Inc. Stock $sens

2021 Q2 Form 10-Q Financial Statement

#000155837021007068 Filed on May 13, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SENS
Senseonics Holdings, Inc. Stock $sens